ART - Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial
Launched by HOSPITAL DO CORACAO · Jun 14, 2011
Trial Information
Current as of July 08, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • intubated, mechanically ventilated patients with diagnosis of moderate to severe ARDS less than 72 hours
- Exclusion Criteria:
- • age less than 18 years
- • use of vasopressor drugs in increasing doses over the last 2 hours or mean arterial blood pressure less than 65mmHg
- • presence of any contraindication to hypercapnia as intracranial hypertension or acute coronary syndrome
- • pneumothorax, pneumomediastinum, subcutaneous emphysema or pneumatocele
- • patient with no therapeutic perspective, candidates for palliative care exclusively
- • patient previously randomized in the ART
About Hospital Do Coracao
Hospital do Coração is a leading medical institution specializing in cardiovascular health and research. Committed to advancing heart care through innovative clinical trials, the hospital integrates cutting-edge technology and evidence-based practices to enhance patient outcomes. With a team of experienced cardiologists, researchers, and healthcare professionals, Hospital do Coração aims to contribute significantly to the global understanding of cardiovascular diseases while providing high-quality care to its patients. The institution fosters a collaborative environment that encourages the development of new therapies and treatments, ultimately striving to improve the quality of life for individuals affected by heart conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sao Paulo, Sp, Brazil
Patients applied
Trial Officials
Alexandre B Cavalcanti, MD, PhD
Principal Investigator
Hospital do Coracao
Carlos RR Carvalho, MD, PhD
Study Chair
Hospital do Coracao, Faculdade de Medicina da Universidade de Sao Paulo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials